MISSISSAUGA, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator and exporter, announces the expansion of its portfolio ...

The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers™ and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ -- ...

The Association for Molecular Pathology (AMP) today published a review of the current benefits and challenges to using multiplex PCR panels for the detection of microbial pathogens from ...

LONDON--(BUSINESS WIRE)--Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs ...

In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, and Parainfluenza, ...

Acute gastroenteritis afflicts adults of all ages, causing significant suffering and inflicting significant costs on the American healthcare system. A new study encompassing nearly 40,000 hospital ...

Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced ...

SYDNEY--(BUSINESS WIRE)--SpeeDx Pty. Ltd. today announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the ...

As SARS-C0V-2 variants emerged, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection, but also to identify the specific variant causing that infection.